Cálculo
Ratio de margen de beneficio operativo | = | 100 | × | Resultado (pérdida) de explotación1 | ÷ | Ventas netas1 | |
---|---|---|---|---|---|---|---|
31 dic 2022 | 13.00% | = | 100 | × | 1,649) | ÷ | 12,682) |
31 dic 2021 | 10.09% | = | 100 | × | 1,199) | ÷ | 11,888) |
31 dic 2020 | -0.81% | = | 100 | × | (80) | ÷ | 9,913) |
31 dic 2019 | 14.14% | = | 100 | × | 1,518) | ÷ | 10,735) |
31 dic 2018 | 15.33% | = | 100 | × | 1,506) | ÷ | 9,823) |
31 dic 2017 | 14.20% | = | 100 | × | 1,285) | ÷ | 9,048) |
31 dic 2016 | 5.33% | = | 100 | × | 447) | ÷ | 8,386) |
31 dic 2015 | -4.37% | = | 100 | × | (327) | ÷ | 7,477) |
31 dic 2014 | -4.08% | = | 100 | × | (301) | ÷ | 7,380) |
31 dic 2013 | 1.68% | = | 100 | × | 120) | ÷ | 7,143) |
31 dic 2012 | -53.36% | = | 100 | × | (3,868) | ÷ | 7,249) |
31 dic 2011 | 11.86% | = | 100 | × | 904) | ÷ | 7,622) |
31 dic 2010 | -8.40% | = | 100 | × | (656) | ÷ | 7,806) |
31 dic 2009 | -10.92% | = | 100 | × | (894) | ÷ | 8,188) |
31 dic 2008 | -18.70% | = | 100 | × | (1,505) | ÷ | 8,050) |
31 dic 2007 | -0.17% | = | 100 | × | (14) | ÷ | 8,357) |
31 dic 2006 | -37.71% | = | 100 | × | (2,949) | ÷ | 7,821) |
31 dic 2005 | 15.41% | = | 100 | × | 968) | ÷ | 6,283) |
Basado en los informes: 10-K (Fecha del informe: 2022-12-31), 10-K (Fecha del informe: 2021-12-31), 10-K (Fecha del informe: 2020-12-31), 10-K (Fecha del informe: 2019-12-31), 10-K (Fecha del informe: 2018-12-31), 10-K (Fecha del informe: 2017-12-31), 10-K (Fecha del informe: 2016-12-31), 10-K (Fecha del informe: 2015-12-31), 10-K (Fecha del informe: 2014-12-31), 10-K (Fecha del informe: 2013-12-31), 10-K (Fecha del informe: 2012-12-31), 10-K (Fecha del informe: 2011-12-31), 10-K (Fecha del informe: 2010-12-31), 10-K (Fecha del informe: 2009-12-31), 10-K (Fecha del informe: 2008-12-31), 10-K (Fecha del informe: 2007-12-31), 10-K (Fecha del informe: 2006-12-31), 10-K (Fecha del informe: 2005-12-31).
1 US$ en millones
Comparación con la competencia
Boston Scientific Corp., ratio de margen de beneficio operativo, tendencias a largo plazo, comparación con los competidores
Boston Scientific Corp. | Abbott Laboratories | CVS Health Corp. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
---|---|---|---|---|---|---|
31 dic 2022 | 13.00% | 19.16% | 2.41% | 25.35% | 18.15% | 8.83% |
31 dic 2021 | 10.09% | 19.56% | 4.54% | 31.89% | 14.89% | 8.40% |
31 dic 2020 | -0.81% | 15.48% | 5.19% | 24.09% | 16.57% | 8.76% |
31 dic 2019 | 14.14% | 14.21% | 4.69% | 30.69% | 20.51% | 8.19% |
31 dic 2018 | 15.33% | 11.94% | 2.07% | 32.21% | 22.20% | 7.71% |
31 dic 2017 | 14.20% | 6.30% | 5.15% | 33.71% | 17.94% | 7.60% |
31 dic 2016 | 5.33% | 15.27% | 5.84% | 34.95% | 18.35% | 7.03% |
31 dic 2015 | -4.37% | 14.05% | 6.18% | 31.04% | 18.59% | 7.05% |
31 dic 2014 | -4.08% | 12.84% | 6.31% | 25.56% | 22.42% | 7.92% |
31 dic 2013 | 1.68% | 12.03% | 6.34% | 37.64% | 26.53% | 7.90% |
31 dic 2012 | -53.36% | 20.28% | 5.87% | 40.30% | 0.00% | 8.42% |
31 dic 2011 | 11.86% | 14.81% | 5.91% | 39.54% | 0.00% | 8.36% |
31 dic 2010 | -8.40% | 17.31% | 6.39% | 39.29% | 0.00% | 8.41% |
31 dic 2009 | -10.92% | 20.27% | 6.52% | 35.87% | 0.00% | 7.35% |
31 dic 2008 | -18.70% | 19.28% | 6.91% | 35.53% | 0.00% | 6.54% |
31 dic 2007 | -0.17% | 17.67% | 6.28% | 34.41% | 0.00% | 10.57% |
31 dic 2006 | -37.71% | 9.09% | 5.57% | 28.81% | 0.00% | 9.88% |
31 dic 2005 | 15.41% | 19.53% | 5.46% | 30.25% | 0.00% | 11.98% |
Basado en los informes: 10-K (Fecha del informe: 2022-12-31), 10-K (Fecha del informe: 2021-12-31), 10-K (Fecha del informe: 2020-12-31), 10-K (Fecha del informe: 2019-12-31), 10-K (Fecha del informe: 2018-12-31), 10-K (Fecha del informe: 2017-12-31), 10-K (Fecha del informe: 2016-12-31), 10-K (Fecha del informe: 2015-12-31), 10-K (Fecha del informe: 2014-12-31), 10-K (Fecha del informe: 2013-12-31), 10-K (Fecha del informe: 2012-12-31), 10-K (Fecha del informe: 2011-12-31), 10-K (Fecha del informe: 2010-12-31), 10-K (Fecha del informe: 2009-12-31), 10-K (Fecha del informe: 2008-12-31), 10-K (Fecha del informe: 2007-12-31), 10-K (Fecha del informe: 2006-12-31), 10-K (Fecha del informe: 2005-12-31).